NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Fulgent Genetics, Inc. (NASDAQ: FLGT) securities between March 22, 2019 and August 4, 2022, both dates including ( the “class period”). If you want to appear as lead plaintiff, you must call the court by November 21, 2022 at the latest.
SO WHAT: If you purchased Fulgent Genetics stock during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join Fulgent Genetics’ class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by November 21, 2022 at the latest. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.
WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Be wise in choosing a lawyer. The Rosen law firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever settlement of a securities class action lawsuit against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named Titan of Plaintiffs’ Bar by Act360. Many of the firm’s attorneys are recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the Complaint, during the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose that: (1) Fulgent Genetics conducted medically unnecessary laboratory testing and engaged in improper billing practices related to, and providing or receiving, laboratory testing of commissions in violation of the Anti-Kickback Act (which prohibits knowingly and intentionally paying a “compensation” to induce or reward patient referrals or to transact business in items or services to be paid for by the government healthcare programs) and that the state Stark statute (which prohibits a physician from referring certain named health care services, including laboratory services, covered by the Medicare program to an entity with which the physician or an immediate family member has a direct or indirect financial relationship) ; (2) accordingly, Fulgent Genetics would likely become subject to increased legal and regulatory scrutiny; (3) Fulgent Genetics’ revenues, to the extent derived from the foregoing illegal conduct, were unsustainable; (4) the foregoing, if disclosed, would be likely to subject the Company to material financial and/or reputational damage; and (5) as a result, the Company’s public statements were, at all relevant times, materially false and misleading. As the true details emerged, the lawsuit alleges that investors suffered damage.
To join Fulgent Genetics’ class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information.
No class was certified. Until a class is certified, you will not be represented by an attorney unless you retain one. You can select a lawyer of your choice. You can also remain absent and do nothing at this point. An investor’s ability to participate in a potential future recovery is not contingent on its serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
lawyer advertising. Previous results do not guarantee a similar result.